121 related articles for article (PubMed ID: 38479158)
1. Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/NLRP3 axis modulation.
Zhang ZW; Tang MQ; Liu W; Song Y; Gao MJ; Ni P; Zhang DD; Mo QG; Zhao BQ
Int Immunopharmacol; 2024 Apr; 131():111785. PubMed ID: 38479158
[TBL] [Abstract][Full Text] [Related]
2. Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO‑1/NLRP3 axis.
Zhang Z; Ni P; Tang M; Song Y; Liu C; Zhao B
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711056
[TBL] [Abstract][Full Text] [Related]
3. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
4. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
Gao Y; Ma Y; Xie D; Jiang H
Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
[TBL] [Abstract][Full Text] [Related]
6. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis.
Hu X; Wang J; Jiang L; Liu X; Ge Q; Wang Q; Qi X; Wu Y
Int Immunopharmacol; 2024 Mar; 130():111790. PubMed ID: 38447417
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
Kim D; Ban KY; Lee GH; Jun HS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373116
[TBL] [Abstract][Full Text] [Related]
8. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
[TBL] [Abstract][Full Text] [Related]
9. FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy.
Xu X; Zhang L; Hua F; Zhang C; Zhang C; Mi X; Qin N; Wang J; Zhu A; Qin Z; Zhou F
Exp Cell Res; 2021 Nov; 408(2):112863. PubMed ID: 34626587
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
11. Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis.
Zhu W; Li YY; Zeng HX; Liu XQ; Sun YT; Jiang L; Xia LL; Wu YG
Int Immunopharmacol; 2021 Dec; 101(Pt B):108236. PubMed ID: 34653727
[TBL] [Abstract][Full Text] [Related]
12. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
Sun L; Ding M; Chen F; Zhu D; Xie X
PeerJ; 2023; 11():e14826. PubMed ID: 36815984
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating
Zhang C; Gong Y; Li N; Liu X; Zhang Y; Ye F; Guo Q; Zheng J
Am J Physiol Cell Physiol; 2021 Mar; 320(3):C355-C364. PubMed ID: 33296289
[TBL] [Abstract][Full Text] [Related]
14. Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway.
Li G; Liu C; Yang L; Feng L; Zhang S; An J; Li J; Gao Y; Pan Z; Xu Y; Liu J; Wang Y; Yan J; Cui J; Qi Z; Yang L
Cell Biol Toxicol; 2023 Jun; 39(3):621-639. PubMed ID: 36640193
[TBL] [Abstract][Full Text] [Related]
15. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
[TBL] [Abstract][Full Text] [Related]
16. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
Zhang Q; Hu Y; Hu JE; Zhang M
Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
[TBL] [Abstract][Full Text] [Related]
17. Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis.
Zhang Y; Liu X; Bai X; Lin Y; Li Z; Fu J; Li M; Zhao T; Yang H; Xu R; Li J; Ju J; Cai B; Xu C; Yang B
J Pineal Res; 2018 Mar; 64(2):. PubMed ID: 29024030
[TBL] [Abstract][Full Text] [Related]
18. GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.
Li X; Jiang X; Jiang M; Wang ZF; Zhao T; Cao SM; Li QM
Acta Diabetol; 2024 Feb; 61(2):225-234. PubMed ID: 37847379
[TBL] [Abstract][Full Text] [Related]
19. [Effect of multi-glycosides of Tripterygium wilfordii on renal injury in diabetic kidney disease rats through NLRP3/caspase-1/GSDMD pyroptosis pathway].
Song CD; Song D; Jia PP; Duan FY; Ding Y; Ren XQ; Zhai WS; Wang YX; Huang SL
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2639-2645. PubMed ID: 37282925
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3.
Liu C; Zhuo H; Ye MY; Huang GX; Fan M; Huang XZ
Kaohsiung J Med Sci; 2020 Sep; 36(9):682-691. PubMed ID: 32391974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
